Your browser doesn't support javascript.
loading
Antituberculosis drugs and hepatotoxicity among hospitalized patients in Jos, Nigeria.
Isa, Samson E; Ebonyi, Augustine O; Shehu, Nathan Y; Idoko, Patrick; Anejo-Okopi, Joseph A; Simji, Gomerep; Odesanya, Rachael U; Abah, Isaac O; Jimoh, Hafsat O.
Afiliação
  • Isa SE; Department of Medicine, University of Jos/Jos University Teaching Hospital, Jos, Nigeria; AIDS Prevention Initiative in Nigeria (APIN), Jos University Teaching Hospital, Jos, Nigeria. Electronic address: ejijisa@yahoo.com.
  • Ebonyi AO; AIDS Prevention Initiative in Nigeria (APIN), Jos University Teaching Hospital, Jos, Nigeria; Department of Pediatrics, University of Jos/Jos University Teaching Hospital, Jos, Nigeria.
  • Shehu NY; Department of Medicine, University of Jos/Jos University Teaching Hospital, Jos, Nigeria; AIDS Prevention Initiative in Nigeria (APIN), Jos University Teaching Hospital, Jos, Nigeria.
  • Idoko P; Department of Medicine, University of Jos/Jos University Teaching Hospital, Jos, Nigeria.
  • Anejo-Okopi JA; AIDS Prevention Initiative in Nigeria (APIN), Jos University Teaching Hospital, Jos, Nigeria; Department of Microbiology, University of Jos, Jos, Nigeria.
  • Simji G; Department of Medicine, University of Jos/Jos University Teaching Hospital, Jos, Nigeria.
  • Odesanya RU; Department of Pharmacy, Jos University Teaching Hospital, Jos, Nigeria.
  • Abah IO; Department of Pharmacy, Jos University Teaching Hospital, Jos, Nigeria.
  • Jimoh HO; Department of Pharmacy, Jos University Teaching Hospital, Jos, Nigeria.
Int J Mycobacteriol ; 5(1): 21-6, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26927986
BACKGROUND: Tuberculosis (TB) could be fatal if left untreated, however, adverse effects of anti-TB medications (anti-TBs) themselves may limit treatment. We determined the incidence and clinical characteristics of hepatotoxicity in hospitalized patients receiving first-line anti-TB treatment. METHODS: A retrospective cohort study of patients aged ⩾18years seen at the medical wards of the Jos University Teaching Hospital from January 2013 to June 2013 was carried out. Data were retrieved for 110 patients who were prescribed anti-TBs. Their demographic and clinical characteristics were described, and the incidence of symptomatic hepatotoxicity determined. The incidence of hepatotoxicity by strict American Thoracic Society criteria (symptomatic hepatotoxicity plus alanine transaminase in IU/L levels >3×upper limit of normal) was also determined. RESULTS: Twenty patients developed symptomatic hepatotoxicity, giving an incidence of 18.2%. Furthermore, 18 (16.4%) patients had hepatotoxicity according to the American Thoracic Society criteria. Those with symptomatic hepatotoxicity unexpectedly had lower baseline alanine transaminase interquartile range (IQR) (35 [16-63] vs. 67 [4-226]; p=.04) and bilirubin (µmol/L): total IQR (15.3 [10.2-74.8] vs. 20.4 [20.4-20.4]; p=.01) and conjugated IQR (7.6 [5.1-34.8] vs. 10.2 [10.2-10.2]; p=.004). However, there were no significant differences in age, sex, body mass index, and duration of anti-TB treatment, human immunodeficiency virus infection status, antiretroviral therapy status, alcohol consumption, and the presence of hepatitis B surface antigen or hepatitis C virus antibody. CONCLUSION: Hepatotoxicity due to first-line anti-TBs, whether based on clinical features alone or backed by liver chemistry, is common among hospitalized patients in our environment. Studies to determine the predictors of hepatotoxicity to guide clinical interventions aimed at the prevention or timely identification of cases are needed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 3_ND Problema de saúde: 2_enfermedades_transmissibles / 3_neglected_diseases / 3_tuberculosis Assunto principal: Tuberculose / Doença Hepática Induzida por Substâncias e Drogas / Fígado / Antituberculosos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: Int J Mycobacteriol Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 3_ND Problema de saúde: 2_enfermedades_transmissibles / 3_neglected_diseases / 3_tuberculosis Assunto principal: Tuberculose / Doença Hepática Induzida por Substâncias e Drogas / Fígado / Antituberculosos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: Int J Mycobacteriol Ano de publicação: 2016 Tipo de documento: Article
...